Your browser doesn't support javascript.
loading
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz, A; Wilmink, J W; Haj Mohammad, N; Hagendoorn, J; de Vos-Geelen, J; Dejong, C H C; Homs, M Y V; Groot Koerkamp, B; van Gulik, T M; van Oijen, M G H; Punt, C J A; Klümpen, H.
Afiliação
  • Belkouz A; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Wilmink JW; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Haj Mohammad N; UMC Utrecht Cancer Center/RAKU, Dept. of Medical Oncology, Utrecht University, Utrecht, the Netherlands.
  • Hagendoorn J; UMC Utrecht Cancer Center/RAKU, Dept. of Surgery, Utrecht University, Utrecht the Netherlands.
  • de Vos-Geelen J; Maastricht UMC+, GROW - School for Oncology and Developmental Biology, Dept. Internal Medicine, Div. of of Medical Oncology, Maastricht, the Netherlands.
  • Dejong CHC; Department of Surgery and School of Nutrition and Translational Research in Metabolism, Maastricht UMC+, Maastricht, the Netherlands and Department of Surgery, Universitätsklinikum Aachen, Aachen, Germany.
  • Homs MYV; Erasmus MC, Dept. of Medical Oncology, Rotterdam, the Netherlands.
  • Groot Koerkamp B; Erasmus MC, Dept. of Surgery Rotterdam, the Netherlands.
  • van Gulik TM; Amsterdam UMC, Dept. of Surgery, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van Oijen MGH; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Punt CJA; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Klümpen H; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: h.klumpen@amsterdamumc.nl.
Crit Rev Oncol Hematol ; 151: 102975, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32464483

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Quimioterapia Adjuvante / Ensaios Clínicos Fase III como Assunto / Ensaios Clínicos Fase II como Assunto / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Quimioterapia Adjuvante / Ensaios Clínicos Fase III como Assunto / Ensaios Clínicos Fase II como Assunto / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda